CHE - Chemed Corporation
NYSE
->
Healthcare
->
Medical Care Facilities
Cincinnati,
United States
Type: Equity
CHE price evolution
CHE
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $222.9 | $313.35 | $263.96 | |
| Short term investments | ||||
| Net receivables | $196.48 | $184.96 | $177.33 | $181.51 |
| Inventory | $9.9 | $10.73 | $10.71 | $12 |
| Total current assets | $490.44 | $464.61 | $539.62 | $500.84 |
| Long term investments | $120.78 | $117.65 | $106.13 | |
| Property, plant & equipment | $335.05 | $334.51 | $334.54 | $330.23 |
| Goodwill & intangible assets | $759.16 | $679.66 | $675.28 | |
| Total noncurrent assets | $1270.37 | $1188.02 | $1167.25 | |
| Total investments | $120.78 | $117.65 | $106.13 | |
| Total assets | $1769.43 | $1734.98 | $1727.63 | $1668.1 |
| Current liabilities | ||||
| Accounts payable | $44.94 | $43 | $56.2 | $64.03 |
| Deferred revenue | ||||
| Short long term debt | $41.17 | $39.28 | $38.63 | |
| Total current liabilities | $264.78 | $261.75 | $281.97 | $312.05 |
| Long term debt | $105.23 | $106.86 | ||
| Total noncurrent liabilities | $265.93 | $262.16 | $248.17 | |
| Total debt | $146.4 | $146.14 | $38.63 | |
| Total liabilities | $533.68 | $527.69 | $544.14 | $560.22 |
| Shareholders' equity | ||||
| Retained earnings | $2639.01 | $2570.72 | $2505.89 | $2446.93 |
| Other shareholder equity | $2.21 | $2.15 | $2.12 | $2.08 |
| Total shareholder equity | $1207.3 | $1183.49 | $1107.88 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $263.96 | $74.13 | $32.9 | $162.68 |
| Short term investments | ||||
| Net receivables | $181.51 | $139.41 | $137.22 | $126.85 |
| Inventory | $12 | $10.27 | $10.11 | $7.09 |
| Total current assets | $500.84 | $272.61 | $230.29 | $329.4 |
| Long term investments | $106.13 | $93.2 | $98.88 | $88.81 |
| Property, plant & equipment | $330.23 | $335.38 | $318.73 | $311.27 |
| Goodwill & intangible assets | $675.28 | $681.02 | $686.69 | $696.67 |
| Total noncurrent assets | $1167.25 | $1169.4 | $1112.44 | $1105.51 |
| Total investments | $106.13 | $93.2 | $98.88 | $88.81 |
| Total assets | $1668.1 | $1442.01 | $1342.72 | $1434.91 |
| Current liabilities | ||||
| Accounts payable | $64.03 | $41.88 | $73.02 | $54.23 |
| Deferred revenue | ||||
| Short long term debt | $38.63 | $44 | $37.91 | $36.2 |
| Total current liabilities | $312.05 | $297.2 | $302.4 | $299.11 |
| Long term debt | $92.5 | $185 | ||
| Total noncurrent liabilities | $248.17 | $346.09 | $417.05 | $234.6 |
| Total debt | $38.63 | $136.5 | $222.91 | $36.2 |
| Total liabilities | $560.22 | $643.3 | $719.45 | $533.71 |
| Shareholders' equity | ||||
| Retained earnings | $2446.93 | $2197.92 | $1970.31 | $1723.78 |
| Other shareholder equity | $2.08 | $2.25 | $2.2 | $2.76 |
| Total shareholder equity | $1107.88 | $798.72 | $623.27 | $901.2 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $606.18 | $595.88 | $589.23 | |
| Cost of revenue | $389.75 | $385.13 | ||
| Gross Profit | $209.99 | $206.13 | $204.11 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $102.25 | $115.87 | ||
| Total operating expenses | $109.12 | $118 | $131.77 | |
| Operating income | $88.13 | $72.33 | ||
| Income from continuing operations | ||||
| EBIT | $94.26 | $84.91 | ||
| Income tax expense | $25.25 | $22.94 | $19.47 | |
| Interest expense | $3.24 | $0.43 | $0.42 | |
| Net income | ||||
| Net income | $75.78 | $70.89 | $65.02 | |
| Income (for common shares) | $70.89 | $65.02 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2264.42 | $2134.96 | $2139.26 | $2079.58 |
| Cost of revenue | $1465.6 | $1369.88 | $1369.46 | $1378.2 |
| Gross Profit | $798.82 | $765.09 | $769.8 | $701.39 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $395.12 | $358.73 | $366.73 | $330.22 |
| Total operating expenses | $458.25 | $421.59 | $426.76 | $311.71 |
| Operating income | $340.57 | $343.5 | $343.04 | $389.68 |
| Income from continuing operations | ||||
| EBIT | $353.48 | $334.26 | $352.18 | $398.35 |
| Income tax expense | $77.86 | $80.06 | $81.76 | $76.52 |
| Interest expense | $3.11 | $4.58 | $1.87 | $2.35 |
| Net income | ||||
| Net income | $272.51 | $249.62 | $268.55 | $319.47 |
| Income (for common shares) | $272.51 | $249.62 | $268.55 | $319.47 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $70.89 | $65.02 | $90.05 | |
| Operating activities | ||||
| Depreciation | $15.71 | $15.81 | $15.54 | |
| Business acquisitions & disposals | -$85 | -$7.3 | ||
| Stock-based compensation | $12.46 | $18.13 | $10.34 | |
| Total cash flows from operations | $77.52 | $84.55 | $108.56 | |
| Investing activities | ||||
| Capital expenditures | -$8.23 | -$12.08 | -$11.64 | |
| Investments | ||||
| Total cash flows from investing | -$131.39 | -$93.49 | -$19.39 | -$11.67 |
| Financing activities | ||||
| Dividends paid | -$19.59 | -$6.06 | -$6.05 | -$6.06 |
| Sale and purchase of stock | -$54.42 | -$1.22 | $3.99 | |
| Net borrowings | -$13.63 | -$2.12 | -$0.43 | |
| Total cash flows from financing | -$146.7 | -$74.47 | -$15.77 | -$6.08 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$25.51 | -$90.45 | $49.39 | $90.81 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $272.51 | $249.62 | $268.55 | $319.47 |
| Operating activities | ||||
| Depreciation | $60.87 | $59.17 | $59.05 | $56.58 |
| Business acquisitions & disposals | -$3.99 | -$3.53 | -$3.6 | |
| Stock-based compensation | $39.35 | $32.44 | $30.25 | $26.8 |
| Total cash flows from operations | $330.3 | $309.89 | $308.6 | $489.29 |
| Investing activities | ||||
| Capital expenditures | -$56.21 | -$54.99 | -$58.67 | -$58.83 |
| Investments | ||||
| Total cash flows from investing | -$60.64 | -$59.4 | -$57.76 | -$61.56 |
| Financing activities | ||||
| Dividends paid | -$23.5 | -$22.02 | -$22.02 | -$21.08 |
| Sale and purchase of stock | $34.49 | -$69.55 | -$576.04 | -$175.59 |
| Net borrowings | -$81.75 | -$100.97 | $196.88 | -$99.85 |
| Total cash flows from financing | -$79.83 | -$209.25 | -$380.62 | -$271.21 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $189.83 | $41.23 | -$129.78 | $156.52 |
News
Fundamentals
| Market cap | $8.41B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 14.93M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 7.38% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.51 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.85 |
| Quick ratio | 1.81 |